GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, ...
Med Device Online36m
Roche Diagnostics Guides New Alzheimer's Test Through Trials
Roche Diagnostics’ Maria-Magdelena Patru, MD, PhD discusses their plasma test and how they’re approaching its clinical trials ...
Medicover: Year-end report January-December 2024
Fourth quarter Revenue amounted to €555.8m (€461.9m), an increase of 20.3% with an organic growth of 18.6%.Operating profit (EBIT) was €23.3m (€19.0m) ...
Money Talks News on MSN1h
Single Blood Draw Claims to Catch 50 Cancers - but Does It Work?
While traditional cancer screenings only cover five types of cancer, a new blood test claims to detect dozens more before ...
What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing
Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...